Cetera Investment Advisers’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144M | Buy |
1,193,872
+55,456
| +5% | +$6.4M | 0.15% | 117 |
|
|
2025
Q4 | $120M | Buy |
1,138,416
+61,979
| +6% | +$5.82M | 0.13% | 134 |
|
|
2025
Q3 | $90.3M | Buy |
1,076,437
+338,470
| +46% | +$27.9M | 0.11% | 180 |
|
|
2025
Q2 | $58.4M | Buy |
737,967
+30,773
| +4% | +$2.45M | 0.1% | 205 |
|
|
2025
Q1 | $63.5M | Buy |
707,194
+26,263
| +4% | +$2.45M | 0.12% | 172 |
|
|
2024
Q4 | $67.7M | Sell |
680,931
-28,696
| -4% | -$2.96M | 0.14% | 148 |
|
|
2024
Q3 | $80.6M | Sell |
709,627
-27,950
| -4% | -$3.32M | 0.18% | 117 |
|
|
2024
Q2 | $91.3M | Sell |
737,577
-28,269
| -4% | -$3.64M | 0.21% | 94 |
|
|
2024
Q1 | $101M | Buy |
765,846
+549,961
| +255% | +$67.8M | 0.24% | 82 |
|
|
2023
Q4 | $23.5M | Sell |
215,885
-15,324
| -7% | -$1.59M | 0.19% | 99 |
|
|
2023
Q3 | $23.8M | Sell |
231,209
-37,146
| -14% | -$4M | 0.21% | 91 |
|
|
2023
Q2 | $31M | Sell |
268,355
-4,089
| -2% | -$464K | 0.26% | 64 |
|
|
2023
Q1 | $29M | Sell |
272,444
-13,694
| -5% | -$1.48M | 0.25% | 74 |
|
|
2022
Q4 | $31.7M | Buy |
286,138
+100,709
| +54% | +$10.3M | 0.29% | 64 |
|
|
2022
Q3 | $16M | Sell |
185,429
-42,163
| -19% | -$3.76M | 0.32% | 63 |
|
|
2022
Q2 | $20.8M | Buy |
227,592
+13,588
| +6% | +$1.2M | 0.33% | 55 |
|
|
2022
Q1 | $17.6M | Buy |
214,004
+20,337
| +11% | +$1.6M | 0.25% | 78 |
|
|
2021
Q4 | $14.8M | Buy |
193,667
+9,349
| +5% | +$745K | 0.21% | 98 |
|
|
2021
Q3 | $13.8M | Buy |
184,318
+3,638
| +2% | +$277K | 0.22% | 98 |
|
|
2021
Q2 | $14.1M | Buy |
180,680
+19,799
| +12% | +$1.47M | 0.23% | 99 |
|
|
2021
Q1 | $11.8M | Sell |
160,881
-13,028
| -7% | -$961K | 0.23% | 94 |
|
|
2020
Q4 | $13.6M | Buy |
173,909
+129,417
| +291% | +$9.9M | 0.27% | 79 |
|
|
2020
Q3 | $3.52M | Buy |
44,492
+2,042
| +5% | +$160K | 0.29% | 85 |
|
|
2020
Q2 | $3.13M | Buy |
42,450
+14,185
| +50% | +$1.07M | 0.29% | 89 |
|
|
2020
Q1 | $2.08M | Buy |
28,265
+5,234
| +23% | +$411K | 0.25% | 112 |
|
|
2019
Q4 | $2M | Buy |
23,031
+1,234
| +6% | +$101K | 0.2% | 130 |
|
|
2019
Q3 | $1.75M | Sell |
21,797
-871
| -4% | -$69.8K | 0.21% | 125 |
|
|
2019
Q2 | $1.81M | Buy |
22,668
+2,803
| +14% | +$215K | 0.23% | 113 |
|
|
2019
Q1 | $1.57M | Buy |
19,865
+1,299
| +7% | +$97.2K | 0.22% | 114 |
|
|
2018
Q4 | $1.36M | Sell |
18,566
-919
| -5% | -$64.9K | 0.22% | 121 |
|
|
2018
Q3 | $1.31M | Buy |
19,485
+2,322
| +14% | +$148K | 0.19% | 131 |
|
|
2018
Q2 | $993K | Buy |
17,163
+470
| +3% | +$26.5K | 0.17% | 149 |
|
|
2018
Q1 | $865K | Sell |
16,693
-3,192
| -16% | -$172K | 0.16% | 158 |
|
|
2017
Q4 | $1.07M | Sell |
19,885
-1,275
| -6% | -$70.7K | 0.2% | 134 |
|
|
2017
Q3 | $1.29M | Sell |
21,160
-40
| -0.2% | -$2.42K | 0.29% | 92 |
|
|
2017
Q2 | $1.29M | Sell |
21,200
-708
| -3% | -$43.1K | 0.32% | 85 |
|
|
2017
Q1 | $1.32M | Buy |
21,908
+2,350
| +12% | +$143K | 0.37% | 81 |
|
|
2016
Q4 | $1.1M | Buy |
19,558
+8,748
| +81% | +$512K | 0.37% | 81 |
|
|
2016
Q3 | $640K | Sell |
10,810
-10,378
| -49% | -$607K | 0.27% | 104 |
|
|
2016
Q2 | $1.17M | Buy |
21,188
+766
| +4% | +$40.8K | 0.46% | 61 |
|
|
2016
Q1 | $1.03M | Buy |
20,422
+3,342
| +20% | +$164K | 0.45% | 59 |
|
|
2015
Q4 | $863K | Buy |
+17,080
| New | +$861K | 0.4% | 69 |
|
Other funds holding MRK
VCM
VPM
Cetera Investment Advisers's MRK Position: Q1 2026 in Review
Cetera Investment Advisers increased its Merck (MRK) stake by 4.9% in Q1 2026, buying an estimated $6.4M and bringing the position to 1,193,872 shares worth $144M. The position accounts for 0.15% of the portfolio, ranked #117.
Cetera Investment Advisers first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Cetera Investment Advisers held 1,193,872 shares of Merck worth $144M as of Q1 2026.
- Cetera Investment Advisers bought 55,456 Merck shares in Q1 2026, an estimated $6.4M.
- Merck made up 0.15% of Cetera Investment Advisers's portfolio in Q1 2026, its #117 holding.
- Cetera Investment Advisers first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.